Only Positional Community
1.27K subscribers
3.46K photos
6 videos
27 files
99 links
Only Positional Community (SEBI unregistered)
Only for educational purpose. Do your own research and analysis before investing, consult your financial advisor before investing.
@rohit_sahjani-NISM SERIES XV/@deepaknankani Admins
Download Telegram
#MASFIN 322-335 should act as good demand zone.
#HEG Retested now 635-645 should act as demand zone. One can keep this 620 neckline as stoploss.
#UNIPARTS
After coming out of big base. It is forming small rounding base consolidation. 485-495 as demand zone.
#AVANTEL is now setting up for potential big move upside after a decent correction.

Stock is now holding 200D SMA.

Demand Zone 150-165
Weak if we close below 136
Upside potential 220-250
This is why market is falling !!
It is fundamentally incorrect to judge the performance of a portfolio concentrated in small-cap, mid-cap, or Nifty 500 stocks by comparing it with the recovery of the Nifty 50. The Nifty 50 represents large-cap leadership stocks, which often recover earlier due to institutional flows, lower volatility, and higher liquidity.

If your portfolio does not contain Nifty 50 constituents, expecting your holdings to move in tandem with that index reflects a misunderstanding of market structure and sectoral rotation. Different market segments recover at different phases of the cycle, and comparing unrelated benchmarks leads to flawed conclusions and poor decision-making.

Performance should always be evaluated against the correct benchmark aligned with your stock universe and risk profile, not against an index your portfolio has no exposure to.
If you are comparing today’s recovery in the Nifty 50 with your portfolio’s performance, first evaluate the segment you are actually invested in. Small-cap, mid-cap, and CNX 500 stocks have not fully recovered yet. Expecting similar performance without exposure to Nifty 50 constituents reflects a mismatch between portfolio composition and benchmark comparison.
The indices have managed to hold key levels and have shown a healthy intraday recovery. As we approach the Union Budget, volatility is expected to remain elevated. At present, the market is navigating through multiple overlapping fundamental events, which naturally increases uncertainty.

That said, the broader trend across all major indices remains intact. What we are witnessing currently is a short-term pullback within an ongoing uptrend, rather than a structural breakdown.
Key overhangs influencing market behavior include:

1. Potential impact of Trump-era tariff discussions resurfacing

2. The upcoming Union Budget

3. Slightly elevated market valuations

4. Ongoing geopolitical tensions and wars

5. Q3 earnings season and forward guidance


6. Rupee Depreciation

Absorbing and pricing in these factors is not a quick process. Historically, such macro and fundamental variables take at least 3–4 months to settle and reflect clearly in price action.

In this phase, our focus should shift from broad index-level expectations to sectoral charts that are technically positioned to resume or initiate an uptrend. Trade setups should be aligned strictly with these stronger sectors, where relative strength and structure are favorable.

Patience remains the key. Avoid impulsive positioning, respect risk management, and continue to trust disciplined setups. Markets reward preparation and conviction far more than reaction.
Markets Don’t Reward Stories. They Reward Timing, Valuations, and Discipline.

In 2025, markets were driven largely by narratives rather than by price discipline.
Investors were sold powerful optimism: India will become the third-largest economy, there is no better place to invest than India, and this is a once-in-a-lifetime, now-or-never opportunity.

The critical point most ignored was valuation.

These optimistic stories were aggressively promoted when market valuations were already stretched, risk-reward had deteriorated, and expectations were priced far ahead of fundamentals. What followed was not surprising. A broad-based correction played out through the year as excesses were unwound and markets reverted to fair value.

Fast forward to today in 2026, and the narrative has completely reversed.
Now we are sold stories of wars, tariffs, global uncertainty, potential crashes, and doubts over India’s growth trajectory. Fear has replaced euphoria, even though valuations are far more reasonable and price structures are stabilizing in several pockets of the market.

This is how market cycles function.

Optimism is sold near tops.
Fear is sold near bottoms.

Smart money does not buy into stories at expensive levels, nor does it exit quality assets during corrections. It accumulates when valuations normalize, expectations reset, and risk-reward improves.

As market participants, our role is not to trade headlines.
Our role is to identify strong sectors, quality stocks, and high-probability technical setups backed by price action and institutional behavior.

We are here to buy setups, not stories.
Narratives will keep changing, but price, structure, and risk-reward always tell the real story.

Those who focus on discipline rather than emotions are the ones who benefit when the cycle turns.
#GROWW is prepared for IPO base breakout

Key levels

Demand Zone 160-165
Upside after breakout 200-250
Stoploss 155
We can see good upside after closing above 170
πŸ‘3
#IFCI

IFCI shares surged 26% in one week following SEBI Chairman's indication that NSE IPO approval may come this month. IFCI benefits from its 52% stake in SHCIL, which holds 4.4% in NSE, creating indirect exposure worth approximately β‚Ή12,000 crores. SEBI is in advanced stages of issuing NOC for NSE's long-awaited IPO, with government approving 2.5% stake dilution.

IFCI shares have experienced a remarkable rally, surging 26% over the past week amid growing expectations that the National Stock Exchange IPO may finally receive regulatory approval. The smallcap PSU stock jumped over 10% to β‚Ή62.56 on BSE during morning trading, though it remains down 1% over the last six months.

Source - Scanx